A recent study conducted at UKE Hamburg compared manual and software-assisted assessments of computed tomography (CT) scans according to iRECIST (immune Response Evaluation Criteria in Solid Tumors) in oncological patients undergoing immune-based treatment. Utilizing mint Lesion™ for software-assisted assessment, the study found that software-assisted assessments resulted in shorter reading times, lower error rates, and higher inter-reader agreement compared to manual assessments. The researchers thus concluded that software-assisted iRECIST assessments are preferable over manual approaches for optimal oncological response evaluation.
Software-Assisted CT Assessment Outperforms Manual Methods in Oncology Study
Related Resources
Related Resources
Unveiling the Predictive Power of Pericardial Effusion in COVID-19 Outcomes
The COVID-19 pandemic wreaked havoc on healthcare systems worldwide, requiring a comprehensive understanding of disease progression for optimal…
Advancing Childhood Cancer Research: The Role of Technology in Brain Tumor Diagnosis and Treatment
Brain cancers account for more than 15% of childhood cancers and are the second most common childhood cancer [1]. Mint Medical is Going Gray in May…
Unlocking the Power of AI: The Vital Role of Structured Reporting
We all know the phrase “a picture is worth a thousand words”; yet, in specific fields, one thousand words are simply too many and can potentially…